Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.49
Delayed Data
As of Feb 17
 -0.03 / -0.85%
Today’s Change
2.85
Today|||52-Week Range
8.75
-1.41%
Year-to-Date

Today’s Trading

Previous close3.52
Today’s open3.49
Day’s range3.45 - 3.55
Volume934,770
Average volume (3 months)2,084,253
Market cap$426.8M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)+1.53%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.19

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.40+4.42%
VIVOMeridian Bioscience ...0.000.00%
OXFDOxford Immunotec Glo...+0.01+0.07%
IMMUImmunomedics Inc+0.22+4.40%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts


Search for Jobs